MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Phase II Study of TAK228 in Relapsed Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
- Status
- COMPLETED
- Phase
- NA
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)
- Status
- COMPLETED
- Phase
- NA
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies
- Status
- COMPLETED
- Phase
- N/A
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers
- Status
- WITHDRAWN
- Phase
- PHASE2
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
URMC Related Haplo-identical Donor BMT
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL
- Status
- UNKNOWN
- Phase
- PHASE1
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
- Status
- COMPLETED
- Phase
- NA
Improving Patient Education for Lymphoma and Leukemia Inpatients
- Status
- COMPLETED
- Phase
- NA